Bionano Genomics, Inc. (BNGO)
Maps DNA structure to find genetic causes of disease and developmental disorders.
$1.10+0.01%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-62.9%
The outlook
BNGO trades near its 52-week low at $1.10, well below both its 50- and 200-day moving averages, signaling a weak near-term trend. Analyst coverage shows a notable disconnect: the average price target sits 357% above the current price, though the overall StockGlow score leans bearish. The stock remains deeply depressed relative to recent highs.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range1% of the way from its 52-week low to high
Price targetAvg target +357% vs current price
Analyst price target
~12-month · 2 analysts$5.00average target+356.6% vs now
Now $1.10
Low $4.00High $6.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$12.6M
52-wk high
$5.50
52-wk low
$1.06
50-day avg
$1.17
200-day avg
$1.37
Trailing P/E
—